nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR1—malignant glioma	0.193	0.301	CbGaD
Pazopanib—FLT1—malignant glioma	0.185	0.287	CbGaD
Pazopanib—PDGFRA—malignant glioma	0.149	0.232	CbGaD
Pazopanib—KDR—malignant glioma	0.116	0.18	CbGaD
Pazopanib—CYP1A2—Carmustine—malignant glioma	0.018	0.569	CbGbCtD
Pazopanib—CYP3A4—Temozolomide—malignant glioma	0.0136	0.43	CbGbCtD
Pazopanib—FGFR3—skull—malignant glioma	0.00366	0.0401	CbGeAlD
Pazopanib—Rilpivirine—CYP2B6—malignant glioma	0.00246	1	CrCbGaD
Pazopanib—FGFR2—skull—malignant glioma	0.0024	0.0262	CbGeAlD
Pazopanib—FLT1—umbilical vein—malignant glioma	0.0021	0.023	CbGeAlD
Pazopanib—Cerebral infarction—Carmustine—malignant glioma	0.002	0.0374	CcSEcCtD
Pazopanib—KDR—umbilical vein—malignant glioma	0.00178	0.0195	CbGeAlD
Pazopanib—FLT4—endothelium—malignant glioma	0.00128	0.014	CbGeAlD
Pazopanib—Transient ischaemic attack—Temozolomide—malignant glioma	0.00125	0.0234	CcSEcCtD
Pazopanib—MAP3K9—telencephalon—malignant glioma	0.00124	0.0136	CbGeAlD
Pazopanib—Lymphopenia—Temozolomide—malignant glioma	0.00123	0.023	CcSEcCtD
Pazopanib—FLT4—blood vessel—malignant glioma	0.00118	0.0129	CbGeAlD
Pazopanib—Cerebral haemorrhage—Carmustine—malignant glioma	0.00118	0.022	CcSEcCtD
Pazopanib—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00114	0.0213	CcSEcCtD
Pazopanib—FGF1—endothelium—malignant glioma	0.00114	0.0125	CbGeAlD
Pazopanib—FGF1—blood vessel—malignant glioma	0.00105	0.0115	CbGeAlD
Pazopanib—Deep vein thrombosis—Temozolomide—malignant glioma	0.00104	0.0194	CcSEcCtD
Pazopanib—Encephalopathy—Carmustine—malignant glioma	0.00102	0.019	CcSEcCtD
Pazopanib—FLT1—endothelium—malignant glioma	0.000996	0.0109	CbGeAlD
Pazopanib—Embolism—Temozolomide—malignant glioma	0.000983	0.0184	CcSEcCtD
Pazopanib—Cyst—Carmustine—malignant glioma	0.000977	0.0182	CcSEcCtD
Pazopanib—SH2B3—retina—malignant glioma	0.000954	0.0105	CbGeAlD
Pazopanib—TAOK1—telencephalon—malignant glioma	0.000932	0.0102	CbGeAlD
Pazopanib—Thrombosis—Carmustine—malignant glioma	0.000922	0.0172	CcSEcCtD
Pazopanib—FLT1—blood vessel—malignant glioma	0.000919	0.0101	CbGeAlD
Pazopanib—FGFR3—embryo—malignant glioma	0.000903	0.00989	CbGeAlD
Pazopanib—MAP3K9—midbrain—malignant glioma	0.000892	0.00977	CbGeAlD
Pazopanib—SH2B3—telencephalon—malignant glioma	0.000878	0.00961	CbGeAlD
Pazopanib—Menorrhagia—Temozolomide—malignant glioma	0.000852	0.0159	CcSEcCtD
Pazopanib—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000852	0.0159	CcSEcCtD
Pazopanib—Hepatotoxicity—Carmustine—malignant glioma	0.000845	0.0158	CcSEcCtD
Pazopanib—KDR—endothelium—malignant glioma	0.000842	0.00923	CbGeAlD
Pazopanib—Hepatotoxicity—Temozolomide—malignant glioma	0.000817	0.0153	CcSEcCtD
Pazopanib—KDR—blood vessel—malignant glioma	0.000777	0.00851	CbGeAlD
Pazopanib—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.000767	0.0143	CcSEcCtD
Pazopanib—Endocrine disorder—Temozolomide—malignant glioma	0.000761	0.0142	CcSEcCtD
Pazopanib—KIT—endothelium—malignant glioma	0.000746	0.00818	CbGeAlD
Pazopanib—FGFR3—telencephalon—malignant glioma	0.000735	0.00805	CbGeAlD
Pazopanib—TAOK1—medulla oblongata—malignant glioma	0.000733	0.00802	CbGeAlD
Pazopanib—MAP3K9—central nervous system—malignant glioma	0.000706	0.00773	CbGeAlD
Pazopanib—FLT4—embryo—malignant glioma	0.000705	0.00772	CbGeAlD
Pazopanib—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000694	0.013	CcSEcCtD
Pazopanib—MAP3K9—cerebellum—malignant glioma	0.00069	0.00756	CbGeAlD
Pazopanib—SH2B3—medulla oblongata—malignant glioma	0.00069	0.00755	CbGeAlD
Pazopanib—KIT—blood vessel—malignant glioma	0.000688	0.00754	CbGeAlD
Pazopanib—PDGFRB—blood vessel—malignant glioma	0.000672	0.00736	CbGeAlD
Pazopanib—TAOK1—midbrain—malignant glioma	0.00067	0.00733	CbGeAlD
Pazopanib—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000667	0.0125	CcSEcCtD
Pazopanib—TAOK1—spinal cord—malignant glioma	0.000653	0.00715	CbGeAlD
Pazopanib—Pulmonary embolism—Carmustine—malignant glioma	0.000653	0.0122	CcSEcCtD
Pazopanib—PI4KB—telencephalon—malignant glioma	0.00065	0.00712	CbGeAlD
Pazopanib—Musculoskeletal pain—Temozolomide—malignant glioma	0.000639	0.0119	CcSEcCtD
Pazopanib—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000631	0.0118	CcSEcCtD
Pazopanib—Pulmonary embolism—Temozolomide—malignant glioma	0.000631	0.0118	CcSEcCtD
Pazopanib—SH2B3—midbrain—malignant glioma	0.00063	0.0069	CbGeAlD
Pazopanib—FGF1—embryo—malignant glioma	0.000626	0.00686	CbGeAlD
Pazopanib—Skin exfoliation—Carmustine—malignant glioma	0.000623	0.0116	CcSEcCtD
Pazopanib—PIP4K2C—retina—malignant glioma	0.00062	0.00679	CbGeAlD
Pazopanib—SH2B3—spinal cord—malignant glioma	0.000615	0.00674	CbGeAlD
Pazopanib—Skin exfoliation—Temozolomide—malignant glioma	0.000602	0.0113	CcSEcCtD
Pazopanib—FGFR2—embryo—malignant glioma	0.000591	0.00648	CbGeAlD
Pazopanib—RIOK2—medulla oblongata—malignant glioma	0.000577	0.00632	CbGeAlD
Pazopanib—FGFR3—medulla oblongata—malignant glioma	0.000577	0.00632	CbGeAlD
Pazopanib—FGF1—brainstem—malignant glioma	0.000574	0.00629	CbGeAlD
Pazopanib—PIP4K2C—telencephalon—malignant glioma	0.00057	0.00625	CbGeAlD
Pazopanib—FGFR1—telencephalon—malignant glioma	0.000566	0.0062	CbGeAlD
Pazopanib—MAP3K9—brain—malignant glioma	0.00056	0.00614	CbGeAlD
Pazopanib—FGF1—retina—malignant glioma	0.000554	0.00606	CbGeAlD
Pazopanib—FLT1—embryo—malignant glioma	0.000548	0.006	CbGeAlD
Pazopanib—FGFR2—brainstem—malignant glioma	0.000542	0.00594	CbGeAlD
Pazopanib—MAP3K2—telencephalon—malignant glioma	0.000541	0.00592	CbGeAlD
Pazopanib—TAOK1—central nervous system—malignant glioma	0.00053	0.0058	CbGeAlD
Pazopanib—FGFR3—midbrain—malignant glioma	0.000528	0.00578	CbGeAlD
Pazopanib—RIOK2—midbrain—malignant glioma	0.000528	0.00578	CbGeAlD
Pazopanib—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000526	0.00984	CcSEcCtD
Pazopanib—STK36—medulla oblongata—malignant glioma	0.000519	0.00568	CbGeAlD
Pazopanib—TAOK1—cerebellum—malignant glioma	0.000518	0.00567	CbGeAlD
Pazopanib—FGFR3—spinal cord—malignant glioma	0.000515	0.00564	CbGeAlD
Pazopanib—RIOK2—spinal cord—malignant glioma	0.000515	0.00564	CbGeAlD
Pazopanib—PDGFRA—embryo—malignant glioma	0.000514	0.00563	CbGeAlD
Pazopanib—PI4KB—medulla oblongata—malignant glioma	0.000511	0.00559	CbGeAlD
Pazopanib—Hepatic failure—Temozolomide—malignant glioma	0.00051	0.00952	CcSEcCtD
Pazopanib—FGF1—telencephalon—malignant glioma	0.000509	0.00558	CbGeAlD
Pazopanib—SH2B3—central nervous system—malignant glioma	0.000499	0.00546	CbGeAlD
Pazopanib—AURKC—central nervous system—malignant glioma	0.000491	0.00538	CbGeAlD
Pazopanib—Hot flush—Temozolomide—malignant glioma	0.00049	0.00915	CcSEcCtD
Pazopanib—SH2B3—cerebellum—malignant glioma	0.000488	0.00534	CbGeAlD
Pazopanib—Menopausal symptoms—Temozolomide—malignant glioma	0.000485	0.00907	CcSEcCtD
Pazopanib—FLT1—retina—malignant glioma	0.000485	0.00531	CbGeAlD
Pazopanib—FGFR2—telencephalon—malignant glioma	0.000481	0.00527	CbGeAlD
Pazopanib—Hyponatraemia—Carmustine—malignant glioma	0.000476	0.00889	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000474	0.00885	CcSEcCtD
Pazopanib—TAOK3—brainstem—malignant glioma	0.000474	0.00519	CbGeAlD
Pazopanib—PI4KB—midbrain—malignant glioma	0.000467	0.00511	CbGeAlD
Pazopanib—KDR—embryo—malignant glioma	0.000463	0.00508	CbGeAlD
Pazopanib—Face oedema—Carmustine—malignant glioma	0.000457	0.00855	CcSEcCtD
Pazopanib—TAOK3—retina—malignant glioma	0.000457	0.00501	CbGeAlD
Pazopanib—PI4KB—spinal cord—malignant glioma	0.000455	0.00499	CbGeAlD
Pazopanib—CSF1R—embryo—malignant glioma	0.000452	0.00495	CbGeAlD
Pazopanib—PIP4K2C—medulla oblongata—malignant glioma	0.000448	0.00491	CbGeAlD
Pazopanib—LIMK2—spinal cord—malignant glioma	0.000447	0.0049	CbGeAlD
Pazopanib—FLT1—telencephalon—malignant glioma	0.000446	0.00488	CbGeAlD
Pazopanib—FGFR1—medulla oblongata—malignant glioma	0.000444	0.00487	CbGeAlD
Pazopanib—Face oedema—Temozolomide—malignant glioma	0.000442	0.00826	CcSEcCtD
Pazopanib—EPHB6—telencephalon—malignant glioma	0.000441	0.00483	CbGeAlD
Pazopanib—Liver function test abnormal—Carmustine—malignant glioma	0.000438	0.00818	CcSEcCtD
Pazopanib—Dehydration—Temozolomide—malignant glioma	0.000426	0.00796	CcSEcCtD
Pazopanib—MAP2K5—brainstem—malignant glioma	0.000425	0.00465	CbGeAlD
Pazopanib—STK16—central nervous system—malignant glioma	0.000424	0.00465	CbGeAlD
Pazopanib—TAOK1—brain—malignant glioma	0.000421	0.00461	CbGeAlD
Pazopanib—TAOK3—telencephalon—malignant glioma	0.00042	0.0046	CbGeAlD
Pazopanib—LYN—central nervous system—malignant glioma	0.00042	0.0046	CbGeAlD
Pazopanib—Dry skin—Temozolomide—malignant glioma	0.00042	0.00784	CcSEcCtD
Pazopanib—PDGFRA—telencephalon—malignant glioma	0.000418	0.00458	CbGeAlD
Pazopanib—RIOK2—central nervous system—malignant glioma	0.000418	0.00457	CbGeAlD
Pazopanib—FGFR3—central nervous system—malignant glioma	0.000418	0.00457	CbGeAlD
Pazopanib—STK16—cerebellum—malignant glioma	0.000415	0.00454	CbGeAlD
Pazopanib—Breast disorder—Temozolomide—malignant glioma	0.000414	0.00773	CcSEcCtD
Pazopanib—MAP3K19—central nervous system—malignant glioma	0.000413	0.00453	CbGeAlD
Pazopanib—BMPR1B—central nervous system—malignant glioma	0.000413	0.00453	CbGeAlD
Pazopanib—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000412	0.00771	CcSEcCtD
Pazopanib—KIT—embryo—malignant glioma	0.000411	0.0045	CbGeAlD
Pazopanib—KDR—retina—malignant glioma	0.00041	0.00449	CbGeAlD
Pazopanib—PIP4K2C—midbrain—malignant glioma	0.000409	0.00449	CbGeAlD
Pazopanib—FGFR3—cerebellum—malignant glioma	0.000408	0.00447	CbGeAlD
Pazopanib—RIOK2—cerebellum—malignant glioma	0.000408	0.00447	CbGeAlD
Pazopanib—FGFR1—midbrain—malignant glioma	0.000406	0.00445	CbGeAlD
Pazopanib—BMPR1B—cerebellum—malignant glioma	0.000404	0.00443	CbGeAlD
Pazopanib—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000404	0.00755	CcSEcCtD
Pazopanib—PDGFRB—embryo—malignant glioma	0.000401	0.00439	CbGeAlD
Pazopanib—FGF1—medulla oblongata—malignant glioma	0.0004	0.00438	CbGeAlD
Pazopanib—PIP4K2C—spinal cord—malignant glioma	0.000399	0.00438	CbGeAlD
Pazopanib—Abdominal distension—Temozolomide—malignant glioma	0.000398	0.00745	CcSEcCtD
Pazopanib—FGFR1—spinal cord—malignant glioma	0.000396	0.00434	CbGeAlD
Pazopanib—SH2B3—brain—malignant glioma	0.000396	0.00434	CbGeAlD
Pazopanib—AURKC—brain—malignant glioma	0.00039	0.00427	CbGeAlD
Pazopanib—Neutropenia—Carmustine—malignant glioma	0.000383	0.00716	CcSEcCtD
Pazopanib—MAP2K5—telencephalon—malignant glioma	0.000377	0.00413	CbGeAlD
Pazopanib—KIT—brainstem—malignant glioma	0.000376	0.00412	CbGeAlD
Pazopanib—STK36—central nervous system—malignant glioma	0.000375	0.00411	CbGeAlD
Pazopanib—Neutropenia—Temozolomide—malignant glioma	0.00037	0.00692	CcSEcCtD
Pazopanib—PI4KB—central nervous system—malignant glioma	0.000369	0.00405	CbGeAlD
Pazopanib—CSF1R—telencephalon—malignant glioma	0.000368	0.00403	CbGeAlD
Pazopanib—STK36—cerebellum—malignant glioma	0.000367	0.00402	CbGeAlD
Pazopanib—FGF1—midbrain—malignant glioma	0.000366	0.00401	CbGeAlD
Pazopanib—LIMK2—central nervous system—malignant glioma	0.000363	0.00397	CbGeAlD
Pazopanib—Photosensitivity reaction—Temozolomide—malignant glioma	0.000361	0.00675	CcSEcCtD
Pazopanib—PI4KB—cerebellum—malignant glioma	0.000361	0.00395	CbGeAlD
Pazopanib—Weight decreased—Temozolomide—malignant glioma	0.000358	0.00669	CcSEcCtD
Pazopanib—FGF1—spinal cord—malignant glioma	0.000357	0.00391	CbGeAlD
Pazopanib—PLK4—brain—malignant glioma	0.000357	0.00391	CbGeAlD
Pazopanib—Stomatitis—Carmustine—malignant glioma	0.000356	0.00665	CcSEcCtD
Pazopanib—LIMK2—cerebellum—malignant glioma	0.000354	0.00388	CbGeAlD
Pazopanib—Infestation—Temozolomide—malignant glioma	0.000353	0.00659	CcSEcCtD
Pazopanib—Infestation NOS—Temozolomide—malignant glioma	0.000353	0.00659	CcSEcCtD
Pazopanib—FLT1—medulla oblongata—malignant glioma	0.00035	0.00384	CbGeAlD
Pazopanib—EPHB6—medulla oblongata—malignant glioma	0.000346	0.00379	CbGeAlD
Pazopanib—Stomatitis—Temozolomide—malignant glioma	0.000344	0.00643	CcSEcCtD
Pazopanib—FGFR2—spinal cord—malignant glioma	0.000337	0.00369	CbGeAlD
Pazopanib—STK16—brain—malignant glioma	0.000337	0.00369	CbGeAlD
Pazopanib—KIT—telencephalon—malignant glioma	0.000334	0.00366	CbGeAlD
Pazopanib—Hepatobiliary disease—Temozolomide—malignant glioma	0.000334	0.00624	CcSEcCtD
Pazopanib—LYN—brain—malignant glioma	0.000333	0.00365	CbGeAlD
Pazopanib—FGFR3—brain—malignant glioma	0.000332	0.00363	CbGeAlD
Pazopanib—RIOK2—brain—malignant glioma	0.000332	0.00363	CbGeAlD
Pazopanib—TAOK3—medulla oblongata—malignant glioma	0.00033	0.00362	CbGeAlD
Pazopanib—Haemoglobin—Carmustine—malignant glioma	0.000329	0.00616	CcSEcCtD
Pazopanib—MAP3K19—brain—malignant glioma	0.000328	0.00359	CbGeAlD
Pazopanib—BMPR1B—brain—malignant glioma	0.000328	0.00359	CbGeAlD
Pazopanib—Haemorrhage—Carmustine—malignant glioma	0.000328	0.00613	CcSEcCtD
Pazopanib—Hypoaesthesia—Carmustine—malignant glioma	0.000326	0.00609	CcSEcCtD
Pazopanib—PDGFRB—telencephalon—malignant glioma	0.000326	0.00357	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—malignant glioma	0.000324	0.00355	CbGeAlD
Pazopanib—Oedema peripheral—Carmustine—malignant glioma	0.000323	0.00603	CcSEcCtD
Pazopanib—Connective tissue disorder—Carmustine—malignant glioma	0.000322	0.00602	CcSEcCtD
Pazopanib—FLT1—midbrain—malignant glioma	0.00032	0.00351	CbGeAlD
Pazopanib—Haemoglobin—Temozolomide—malignant glioma	0.000318	0.00595	CcSEcCtD
Pazopanib—Haemorrhage—Temozolomide—malignant glioma	0.000317	0.00592	CcSEcCtD
Pazopanib—PIP4K2C—cerebellum—malignant glioma	0.000317	0.00347	CbGeAlD
Pazopanib—EPHB6—midbrain—malignant glioma	0.000316	0.00347	CbGeAlD
Pazopanib—Hypoaesthesia—Temozolomide—malignant glioma	0.000315	0.00589	CcSEcCtD
Pazopanib—FGFR1—cerebellum—malignant glioma	0.000314	0.00344	CbGeAlD
Pazopanib—Urinary tract disorder—Temozolomide—malignant glioma	0.000313	0.00585	CcSEcCtD
Pazopanib—FLT1—spinal cord—malignant glioma	0.000312	0.00342	CbGeAlD
Pazopanib—Oedema peripheral—Temozolomide—malignant glioma	0.000312	0.00583	CcSEcCtD
Pazopanib—Connective tissue disorder—Temozolomide—malignant glioma	0.000311	0.00582	CcSEcCtD
Pazopanib—Urethral disorder—Temozolomide—malignant glioma	0.000311	0.0058	CcSEcCtD
Pazopanib—EPHB6—spinal cord—malignant glioma	0.000309	0.00338	CbGeAlD
Pazopanib—MAP3K2—central nervous system—malignant glioma	0.000307	0.00337	CbGeAlD
Pazopanib—Eye disorder—Carmustine—malignant glioma	0.000306	0.00572	CcSEcCtD
Pazopanib—Flushing—Carmustine—malignant glioma	0.000304	0.00569	CcSEcCtD
Pazopanib—TAOK3—midbrain—malignant glioma	0.000302	0.00331	CbGeAlD
Pazopanib—MAP3K2—cerebellum—malignant glioma	0.0003	0.00329	CbGeAlD
Pazopanib—STK36—brain—malignant glioma	0.000298	0.00326	CbGeAlD
Pazopanib—KDR—medulla oblongata—malignant glioma	0.000296	0.00324	CbGeAlD
Pazopanib—MAP2K5—medulla oblongata—malignant glioma	0.000296	0.00324	CbGeAlD
Pazopanib—Eye disorder—Temozolomide—malignant glioma	0.000296	0.00553	CcSEcCtD
Pazopanib—TAOK3—spinal cord—malignant glioma	0.000295	0.00323	CbGeAlD
Pazopanib—Flushing—Temozolomide—malignant glioma	0.000294	0.00549	CcSEcCtD
Pazopanib—Cardiac disorder—Temozolomide—malignant glioma	0.000294	0.00549	CcSEcCtD
Pazopanib—PI4KB—brain—malignant glioma	0.000293	0.00321	CbGeAlD
Pazopanib—PDGFRA—spinal cord—malignant glioma	0.000293	0.00321	CbGeAlD
Pazopanib—Alopecia—Carmustine—malignant glioma	0.00029	0.00541	CcSEcCtD
Pazopanib—FGF1—central nervous system—malignant glioma	0.000289	0.00317	CbGeAlD
Pazopanib—CSF1R—medulla oblongata—malignant glioma	0.000289	0.00316	CbGeAlD
Pazopanib—LIMK2—brain—malignant glioma	0.000288	0.00315	CbGeAlD
Pazopanib—Angiopathy—Temozolomide—malignant glioma	0.000287	0.00537	CcSEcCtD
Pazopanib—Mental disorder—Carmustine—malignant glioma	0.000287	0.00537	CcSEcCtD
Pazopanib—Mediastinal disorder—Temozolomide—malignant glioma	0.000286	0.00534	CcSEcCtD
Pazopanib—Erythema—Carmustine—malignant glioma	0.000285	0.00533	CcSEcCtD
Pazopanib—Malnutrition—Carmustine—malignant glioma	0.000285	0.00533	CcSEcCtD
Pazopanib—Chills—Temozolomide—malignant glioma	0.000284	0.00531	CcSEcCtD
Pazopanib—FGF1—cerebellum—malignant glioma	0.000283	0.0031	CbGeAlD
Pazopanib—Alopecia—Temozolomide—malignant glioma	0.00028	0.00523	CcSEcCtD
Pazopanib—Mental disorder—Temozolomide—malignant glioma	0.000278	0.00519	CcSEcCtD
Pazopanib—Malnutrition—Temozolomide—malignant glioma	0.000276	0.00515	CcSEcCtD
Pazopanib—Erythema—Temozolomide—malignant glioma	0.000276	0.00515	CcSEcCtD
Pazopanib—FGFR2—central nervous system—malignant glioma	0.000273	0.00299	CbGeAlD
Pazopanib—KDR—midbrain—malignant glioma	0.000271	0.00296	CbGeAlD
Pazopanib—MAP2K5—midbrain—malignant glioma	0.000271	0.00296	CbGeAlD
Pazopanib—Dysgeusia—Temozolomide—malignant glioma	0.00027	0.00505	CcSEcCtD
Pazopanib—Vision blurred—Carmustine—malignant glioma	0.000269	0.00503	CcSEcCtD
Pazopanib—FGFR2—cerebellum—malignant glioma	0.000267	0.00293	CbGeAlD
Pazopanib—CSF1R—midbrain—malignant glioma	0.000264	0.00289	CbGeAlD
Pazopanib—KDR—spinal cord—malignant glioma	0.000264	0.00289	CbGeAlD
Pazopanib—MAP2K5—spinal cord—malignant glioma	0.000264	0.00289	CbGeAlD
Pazopanib—Anaemia—Carmustine—malignant glioma	0.000264	0.00493	CcSEcCtD
Pazopanib—KIT—medulla oblongata—malignant glioma	0.000262	0.00287	CbGeAlD
Pazopanib—Vision blurred—Temozolomide—malignant glioma	0.00026	0.00486	CcSEcCtD
Pazopanib—FLT4—brain—malignant glioma	0.000259	0.00283	CbGeAlD
Pazopanib—CSF1R—spinal cord—malignant glioma	0.000258	0.00282	CbGeAlD
Pazopanib—PIP4K2C—brain—malignant glioma	0.000257	0.00282	CbGeAlD
Pazopanib—PDGFRB—medulla oblongata—malignant glioma	0.000256	0.00281	CbGeAlD
Pazopanib—Leukopenia—Carmustine—malignant glioma	0.000255	0.00477	CcSEcCtD
Pazopanib—FGFR1—brain—malignant glioma	0.000255	0.0028	CbGeAlD
Pazopanib—Anaemia—Temozolomide—malignant glioma	0.000255	0.00476	CcSEcCtD
Pazopanib—FLT1—central nervous system—malignant glioma	0.000253	0.00278	CbGeAlD
Pazopanib—EPHB6—central nervous system—malignant glioma	0.00025	0.00274	CbGeAlD
Pazopanib—FLT1—cerebellum—malignant glioma	0.000248	0.00271	CbGeAlD
Pazopanib—Leukopenia—Temozolomide—malignant glioma	0.000247	0.00461	CcSEcCtD
Pazopanib—Hypertension—Carmustine—malignant glioma	0.000246	0.0046	CcSEcCtD
Pazopanib—EPHB6—cerebellum—malignant glioma	0.000245	0.00268	CbGeAlD
Pazopanib—MAP3K2—brain—malignant glioma	0.000244	0.00267	CbGeAlD
Pazopanib—Chest pain—Carmustine—malignant glioma	0.000243	0.00454	CcSEcCtD
Pazopanib—Myalgia—Carmustine—malignant glioma	0.000243	0.00454	CcSEcCtD
Pazopanib—Cough—Temozolomide—malignant glioma	0.000241	0.0045	CcSEcCtD
Pazopanib—STK10—central nervous system—malignant glioma	0.00024	0.00263	CbGeAlD
Pazopanib—KIT—midbrain—malignant glioma	0.00024	0.00263	CbGeAlD
Pazopanib—TAOK3—central nervous system—malignant glioma	0.000239	0.00262	CbGeAlD
Pazopanib—Hypertension—Temozolomide—malignant glioma	0.000238	0.00445	CcSEcCtD
Pazopanib—PDGFRA—central nervous system—malignant glioma	0.000237	0.0026	CbGeAlD
Pazopanib—Myalgia—Temozolomide—malignant glioma	0.000235	0.00439	CcSEcCtD
Pazopanib—Arthralgia—Temozolomide—malignant glioma	0.000235	0.00439	CcSEcCtD
Pazopanib—STK10—cerebellum—malignant glioma	0.000234	0.00257	CbGeAlD
Pazopanib—PDGFRB—midbrain—malignant glioma	0.000234	0.00257	CbGeAlD
Pazopanib—KIT—spinal cord—malignant glioma	0.000234	0.00256	CbGeAlD
Pazopanib—TAOK3—cerebellum—malignant glioma	0.000234	0.00256	CbGeAlD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000233	0.00436	CcSEcCtD
Pazopanib—Oedema—Carmustine—malignant glioma	0.000233	0.00435	CcSEcCtD
Pazopanib—PDGFRA—cerebellum—malignant glioma	0.000232	0.00254	CbGeAlD
Pazopanib—Infection—Carmustine—malignant glioma	0.000231	0.00432	CcSEcCtD
Pazopanib—FGF1—brain—malignant glioma	0.00023	0.00252	CbGeAlD
Pazopanib—Dry mouth—Temozolomide—malignant glioma	0.00023	0.00429	CcSEcCtD
Pazopanib—PDGFRB—spinal cord—malignant glioma	0.000229	0.0025	CbGeAlD
Pazopanib—Thrombocytopenia—Carmustine—malignant glioma	0.000228	0.00426	CcSEcCtD
Pazopanib—Oedema—Temozolomide—malignant glioma	0.000225	0.00421	CcSEcCtD
Pazopanib—Infection—Temozolomide—malignant glioma	0.000224	0.00418	CcSEcCtD
Pazopanib—Anorexia—Carmustine—malignant glioma	0.000222	0.00415	CcSEcCtD
Pazopanib—Nervous system disorder—Temozolomide—malignant glioma	0.000221	0.00412	CcSEcCtD
Pazopanib—Thrombocytopenia—Temozolomide—malignant glioma	0.00022	0.00412	CcSEcCtD
Pazopanib—Skin disorder—Temozolomide—malignant glioma	0.000219	0.00409	CcSEcCtD
Pazopanib—Hyperhidrosis—Temozolomide—malignant glioma	0.000218	0.00407	CcSEcCtD
Pazopanib—FGFR2—brain—malignant glioma	0.000217	0.00238	CbGeAlD
Pazopanib—Anorexia—Temozolomide—malignant glioma	0.000215	0.00401	CcSEcCtD
Pazopanib—KDR—central nervous system—malignant glioma	0.000214	0.00235	CbGeAlD
Pazopanib—MAP2K5—central nervous system—malignant glioma	0.000214	0.00235	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000212	0.00397	CcSEcCtD
Pazopanib—Insomnia—Carmustine—malignant glioma	0.000211	0.00394	CcSEcCtD
Pazopanib—KDR—cerebellum—malignant glioma	0.000209	0.00229	CbGeAlD
Pazopanib—MAP2K5—cerebellum—malignant glioma	0.000209	0.00229	CbGeAlD
Pazopanib—Paraesthesia—Carmustine—malignant glioma	0.000209	0.00391	CcSEcCtD
Pazopanib—CSF1R—central nervous system—malignant glioma	0.000209	0.00229	CbGeAlD
Pazopanib—Dyspnoea—Carmustine—malignant glioma	0.000208	0.00388	CcSEcCtD
Pazopanib—Somnolence—Carmustine—malignant glioma	0.000207	0.00387	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000205	0.00383	CcSEcCtD
Pazopanib—CSF1R—cerebellum—malignant glioma	0.000204	0.00224	CbGeAlD
Pazopanib—Insomnia—Temozolomide—malignant glioma	0.000204	0.0038	CcSEcCtD
Pazopanib—Decreased appetite—Carmustine—malignant glioma	0.000202	0.00378	CcSEcCtD
Pazopanib—Paraesthesia—Temozolomide—malignant glioma	0.000202	0.00378	CcSEcCtD
Pazopanib—FLT1—brain—malignant glioma	0.000201	0.0022	CbGeAlD
Pazopanib—Gastrointestinal disorder—Carmustine—malignant glioma	0.000201	0.00376	CcSEcCtD
Pazopanib—Dyspnoea—Temozolomide—malignant glioma	0.000201	0.00375	CcSEcCtD
Pazopanib—Somnolence—Temozolomide—malignant glioma	0.0002	0.00374	CcSEcCtD
Pazopanib—Pain—Carmustine—malignant glioma	0.000199	0.00372	CcSEcCtD
Pazopanib—EPHB6—brain—malignant glioma	0.000199	0.00218	CbGeAlD
Pazopanib—Dyspepsia—Temozolomide—malignant glioma	0.000198	0.0037	CcSEcCtD
Pazopanib—Decreased appetite—Temozolomide—malignant glioma	0.000196	0.00366	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000194	0.00363	CcSEcCtD
Pazopanib—Fatigue—Temozolomide—malignant glioma	0.000194	0.00363	CcSEcCtD
Pazopanib—Pain—Temozolomide—malignant glioma	0.000192	0.0036	CcSEcCtD
Pazopanib—Gastrointestinal pain—Carmustine—malignant glioma	0.00019	0.00356	CcSEcCtD
Pazopanib—STK10—brain—malignant glioma	0.00019	0.00209	CbGeAlD
Pazopanib—KIT—central nervous system—malignant glioma	0.00019	0.00208	CbGeAlD
Pazopanib—TAOK3—brain—malignant glioma	0.00019	0.00208	CbGeAlD
Pazopanib—PDGFRA—brain—malignant glioma	0.000188	0.00206	CbGeAlD
Pazopanib—ABCB1—blood vessel—malignant glioma	0.000186	0.00204	CbGeAlD
Pazopanib—KIT—cerebellum—malignant glioma	0.000186	0.00203	CbGeAlD
Pazopanib—PDGFRB—central nervous system—malignant glioma	0.000185	0.00203	CbGeAlD
Pazopanib—Abdominal pain—Carmustine—malignant glioma	0.000184	0.00344	CcSEcCtD
Pazopanib—Gastrointestinal pain—Temozolomide—malignant glioma	0.000184	0.00344	CcSEcCtD
Pazopanib—ABCG2—telencephalon—malignant glioma	0.000183	0.00201	CbGeAlD
Pazopanib—PDGFRB—cerebellum—malignant glioma	0.000181	0.00198	CbGeAlD
Pazopanib—Abdominal pain—Temozolomide—malignant glioma	0.000178	0.00332	CcSEcCtD
Pazopanib—KDR—brain—malignant glioma	0.00017	0.00186	CbGeAlD
Pazopanib—MAP2K5—brain—malignant glioma	0.00017	0.00186	CbGeAlD
Pazopanib—Asthenia—Carmustine—malignant glioma	0.000167	0.00312	CcSEcCtD
Pazopanib—CSF1R—brain—malignant glioma	0.000166	0.00182	CbGeAlD
Pazopanib—Asthenia—Temozolomide—malignant glioma	0.000161	0.00302	CcSEcCtD
Pazopanib—Diarrhoea—Carmustine—malignant glioma	0.000159	0.00298	CcSEcCtD
Pazopanib—Pruritus—Temozolomide—malignant glioma	0.000159	0.00298	CcSEcCtD
Pazopanib—Dizziness—Carmustine—malignant glioma	0.000154	0.00288	CcSEcCtD
Pazopanib—Diarrhoea—Temozolomide—malignant glioma	0.000154	0.00288	CcSEcCtD
Pazopanib—KIT—brain—malignant glioma	0.000151	0.00165	CbGeAlD
Pazopanib—Dizziness—Temozolomide—malignant glioma	0.000149	0.00278	CcSEcCtD
Pazopanib—Vomiting—Carmustine—malignant glioma	0.000148	0.00277	CcSEcCtD
Pazopanib—PDGFRB—brain—malignant glioma	0.000147	0.00161	CbGeAlD
Pazopanib—Rash—Carmustine—malignant glioma	0.000147	0.00274	CcSEcCtD
Pazopanib—Dermatitis—Carmustine—malignant glioma	0.000147	0.00274	CcSEcCtD
Pazopanib—Headache—Carmustine—malignant glioma	0.000146	0.00273	CcSEcCtD
Pazopanib—ABCG2—medulla oblongata—malignant glioma	0.000144	0.00158	CbGeAlD
Pazopanib—Vomiting—Temozolomide—malignant glioma	0.000143	0.00267	CcSEcCtD
Pazopanib—Rash—Temozolomide—malignant glioma	0.000142	0.00265	CcSEcCtD
Pazopanib—Dermatitis—Temozolomide—malignant glioma	0.000142	0.00265	CcSEcCtD
Pazopanib—CYP2D6—brainstem—malignant glioma	0.000142	0.00155	CbGeAlD
Pazopanib—Headache—Temozolomide—malignant glioma	0.000141	0.00263	CcSEcCtD
Pazopanib—Nausea—Carmustine—malignant glioma	0.000138	0.00259	CcSEcCtD
Pazopanib—Nausea—Temozolomide—malignant glioma	0.000134	0.0025	CcSEcCtD
Pazopanib—ABCG2—midbrain—malignant glioma	0.000132	0.00144	CbGeAlD
Pazopanib—ABCG2—spinal cord—malignant glioma	0.000128	0.00141	CbGeAlD
Pazopanib—CYP2D6—telencephalon—malignant glioma	0.000126	0.00138	CbGeAlD
Pazopanib—ABCB1—embryo—malignant glioma	0.000111	0.00122	CbGeAlD
Pazopanib—ABCG2—cerebellum—malignant glioma	0.000102	0.00112	CbGeAlD
Pazopanib—ABCB1—retina—malignant glioma	9.83e-05	0.00108	CbGeAlD
Pazopanib—ABCB1—telencephalon—malignant glioma	9.04e-05	0.00099	CbGeAlD
Pazopanib—CYP2C8—brain—malignant glioma	8.51e-05	0.000932	CbGeAlD
Pazopanib—ABCG2—brain—malignant glioma	8.27e-05	0.000906	CbGeAlD
Pazopanib—CYP3A4—central nervous system—malignant glioma	7.26e-05	0.000795	CbGeAlD
Pazopanib—CYP2D6—central nervous system—malignant glioma	7.14e-05	0.000782	CbGeAlD
Pazopanib—ABCB1—medulla oblongata—malignant glioma	7.1e-05	0.000778	CbGeAlD
Pazopanib—CYP2D6—cerebellum—malignant glioma	6.98e-05	0.000765	CbGeAlD
Pazopanib—ABCB1—midbrain—malignant glioma	6.49e-05	0.000711	CbGeAlD
Pazopanib—ABCB1—spinal cord—malignant glioma	6.33e-05	0.000694	CbGeAlD
Pazopanib—CYP2D6—brain—malignant glioma	5.67e-05	0.000621	CbGeAlD
Pazopanib—ABCB1—central nervous system—malignant glioma	5.14e-05	0.000563	CbGeAlD
Pazopanib—ABCB1—cerebellum—malignant glioma	5.02e-05	0.00055	CbGeAlD
Pazopanib—ABCB1—brain—malignant glioma	4.08e-05	0.000447	CbGeAlD
Pazopanib—LYN—Immune System—EGFR—malignant glioma	1.41e-06	7.89e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EGFR—malignant glioma	1.41e-06	7.88e-06	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—AKT1—malignant glioma	1.41e-06	7.88e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—PIK3CA—malignant glioma	1.41e-06	7.85e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.4e-06	7.84e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—KRAS—malignant glioma	1.4e-06	7.83e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—KRAS—malignant glioma	1.4e-06	7.81e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PIK3CA—malignant glioma	1.39e-06	7.79e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CD80—malignant glioma	1.39e-06	7.79e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CG—malignant glioma	1.39e-06	7.77e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APC—malignant glioma	1.39e-06	7.77e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PIK3CA—malignant glioma	1.39e-06	7.77e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PIK3CA—malignant glioma	1.38e-06	7.71e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—malignant glioma	1.38e-06	7.7e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS1—malignant glioma	1.38e-06	7.7e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MYC—malignant glioma	1.38e-06	7.69e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGF—malignant glioma	1.38e-06	7.68e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.37e-06	7.67e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PTEN—malignant glioma	1.37e-06	7.66e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KRAS—malignant glioma	1.37e-06	7.64e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTPN11—malignant glioma	1.37e-06	7.64e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MDM2—malignant glioma	1.37e-06	7.63e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—KRAS—malignant glioma	1.36e-06	7.62e-06	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKT1—malignant glioma	1.36e-06	7.62e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—MYC—malignant glioma	1.36e-06	7.61e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RAF1—malignant glioma	1.36e-06	7.6e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—malignant glioma	1.36e-06	7.6e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CASP3—malignant glioma	1.36e-06	7.6e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—malignant glioma	1.36e-06	7.59e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CASP3—malignant glioma	1.36e-06	7.58e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—PIK3CA—malignant glioma	1.36e-06	7.58e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—malignant glioma	1.35e-06	7.57e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—malignant glioma	1.35e-06	7.57e-06	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—AKT1—malignant glioma	1.35e-06	7.56e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NCOR1—malignant glioma	1.35e-06	7.53e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EGFR—malignant glioma	1.35e-06	7.52e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ERBB2—malignant glioma	1.35e-06	7.52e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PTEN—malignant glioma	1.35e-06	7.52e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MDM2—malignant glioma	1.34e-06	7.47e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—KRAS—malignant glioma	1.33e-06	7.46e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3CB—malignant glioma	1.33e-06	7.45e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—KRAS—malignant glioma	1.33e-06	7.45e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EGFR—malignant glioma	1.33e-06	7.44e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RAF1—malignant glioma	1.33e-06	7.44e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CB—malignant glioma	1.33e-06	7.42e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—malignant glioma	1.32e-06	7.38e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ERBB2—malignant glioma	1.32e-06	7.36e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PTEN—malignant glioma	1.32e-06	7.35e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—BRAF—malignant glioma	1.31e-06	7.31e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CB—malignant glioma	1.3e-06	7.27e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PIK3CA—malignant glioma	1.29e-06	7.19e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—malignant glioma	1.28e-06	7.18e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PIK3CA—malignant glioma	1.28e-06	7.17e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—malignant glioma	1.28e-06	7.16e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—BCHE—malignant glioma	1.28e-06	7.16e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PTEN—malignant glioma	1.28e-06	7.14e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTP1—malignant glioma	1.28e-06	7.14e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—malignant glioma	1.28e-06	7.13e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—STAT3—malignant glioma	1.27e-06	7.12e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PTEN—malignant glioma	1.27e-06	7.12e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT2—malignant glioma	1.27e-06	7.11e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KRAS—malignant glioma	1.27e-06	7.11e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.27e-06	7.07e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KRAS—malignant glioma	1.26e-06	7.03e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTEN—malignant glioma	1.26e-06	7.03e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PIK3CA—malignant glioma	1.26e-06	7.02e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PIK3CA—malignant glioma	1.25e-06	7e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—malignant glioma	1.25e-06	6.98e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAT—malignant glioma	1.24e-06	6.94e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—malignant glioma	1.24e-06	6.92e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CB—malignant glioma	1.24e-06	6.9e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—PIK3CA—malignant glioma	1.23e-06	6.85e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—STAT3—malignant glioma	1.23e-06	6.85e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PIK3CA—malignant glioma	1.22e-06	6.84e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—malignant glioma	1.22e-06	6.84e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CD—malignant glioma	1.22e-06	6.83e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CASP3—malignant glioma	1.22e-06	6.83e-06	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—malignant glioma	1.22e-06	6.83e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—malignant glioma	1.22e-06	6.82e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—malignant glioma	1.22e-06	6.79e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—malignant glioma	1.22e-06	6.79e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—malignant glioma	1.2e-06	6.73e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTP1—malignant glioma	1.2e-06	6.72e-06	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—malignant glioma	1.2e-06	6.7e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.2e-06	6.69e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CASP3—malignant glioma	1.2e-06	6.68e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—malignant glioma	1.19e-06	6.67e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.19e-06	6.63e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—malignant glioma	1.18e-06	6.62e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—malignant glioma	1.18e-06	6.57e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NCOR1—malignant glioma	1.17e-06	6.56e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAT—malignant glioma	1.17e-06	6.54e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FGF2—malignant glioma	1.17e-06	6.54e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PIK3CA—malignant glioma	1.17e-06	6.53e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—EGFR—malignant glioma	1.16e-06	6.47e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PIK3CA—malignant glioma	1.16e-06	6.46e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—malignant glioma	1.15e-06	6.45e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—malignant glioma	1.15e-06	6.45e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTEN—malignant glioma	1.15e-06	6.44e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—malignant glioma	1.15e-06	6.43e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—malignant glioma	1.15e-06	6.42e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PTEN—malignant glioma	1.15e-06	6.41e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—malignant glioma	1.14e-06	6.38e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—malignant glioma	1.14e-06	6.37e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MYC—malignant glioma	1.14e-06	6.36e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—malignant glioma	1.14e-06	6.36e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—malignant glioma	1.14e-06	6.35e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTT1—malignant glioma	1.14e-06	6.34e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—malignant glioma	1.13e-06	6.32e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—malignant glioma	1.13e-06	6.32e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—malignant glioma	1.13e-06	6.3e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PTEN—malignant glioma	1.12e-06	6.28e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MYC—malignant glioma	1.12e-06	6.25e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EGFR—malignant glioma	1.11e-06	6.22e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—malignant glioma	1.11e-06	6.19e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NCOR1—malignant glioma	1.11e-06	6.18e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAV1—malignant glioma	1.1e-06	6.14e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MDM2—malignant glioma	1.1e-06	6.12e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EGFR—malignant glioma	1.09e-06	6.11e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—KRAS—malignant glioma	1.09e-06	6.11e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MYC—malignant glioma	1.09e-06	6.11e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RAF1—malignant glioma	1.09e-06	6.1e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ERBB2—malignant glioma	1.08e-06	6.04e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—EGFR—malignant glioma	1.07e-06	5.97e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTEN—malignant glioma	1.07e-06	5.96e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CB—malignant glioma	1.07e-06	5.96e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS1—malignant glioma	1.06e-06	5.94e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MYC—malignant glioma	1.06e-06	5.93e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MYC—malignant glioma	1.06e-06	5.92e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KRAS—malignant glioma	1.05e-06	5.88e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—malignant glioma	1.05e-06	5.87e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.05e-06	5.86e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—malignant glioma	1.05e-06	5.86e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EGFR—malignant glioma	1.04e-06	5.8e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—malignant glioma	1.04e-06	5.79e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EGFR—malignant glioma	1.04e-06	5.79e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.03e-06	5.78e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KRAS—malignant glioma	1.03e-06	5.78e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—malignant glioma	1.03e-06	5.74e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—malignant glioma	1.03e-06	5.74e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—malignant glioma	1.02e-06	5.72e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—malignant glioma	1.02e-06	5.72e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTP1—malignant glioma	1.02e-06	5.7e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—malignant glioma	1.02e-06	5.67e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—KRAS—malignant glioma	1.01e-06	5.64e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—PIK3CA—malignant glioma	1.01e-06	5.62e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—malignant glioma	1.01e-06	5.62e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—malignant glioma	1e-06	5.6e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—malignant glioma	1e-06	5.59e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CG—malignant glioma	1e-06	5.59e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAT—malignant glioma	9.92e-07	5.54e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—BCHE—malignant glioma	9.89e-07	5.53e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KRAS—malignant glioma	9.81e-07	5.48e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CASP3—malignant glioma	9.81e-07	5.48e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—malignant glioma	9.79e-07	5.47e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KRAS—malignant glioma	9.78e-07	5.47e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.77e-07	5.46e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PIK3CA—malignant glioma	9.67e-07	5.4e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—malignant glioma	9.65e-07	5.39e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAV1—malignant glioma	9.57e-07	5.35e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—malignant glioma	9.54e-07	5.33e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MYC—malignant glioma	9.54e-07	5.33e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PIK3CA—malignant glioma	9.5e-07	5.31e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—malignant glioma	9.45e-07	5.28e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NCOR1—malignant glioma	9.37e-07	5.23e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—malignant glioma	9.35e-07	5.23e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MYC—malignant glioma	9.34e-07	5.22e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGFR—malignant glioma	9.33e-07	5.21e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PIK3CA—malignant glioma	9.28e-07	5.19e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—malignant glioma	9.27e-07	5.18e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTEN—malignant glioma	9.21e-07	5.15e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—malignant glioma	9.19e-07	5.13e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGFR—malignant glioma	9.14e-07	5.1e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAV1—malignant glioma	9.02e-07	5.04e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PIK3CA—malignant glioma	9.01e-07	5.04e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PIK3CA—malignant glioma	8.99e-07	5.02e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PIK3CA—malignant glioma	8.87e-07	4.96e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KRAS—malignant glioma	8.81e-07	4.93e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CD—malignant glioma	8.79e-07	4.91e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—malignant glioma	8.72e-07	4.87e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CG—malignant glioma	8.71e-07	4.87e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—malignant glioma	8.7e-07	4.86e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KRAS—malignant glioma	8.63e-07	4.82e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—malignant glioma	8.41e-07	4.7e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—malignant glioma	8.32e-07	4.65e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—malignant glioma	8.24e-07	4.6e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CG—malignant glioma	8.21e-07	4.59e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—malignant glioma	8.21e-07	4.59e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3CA—malignant glioma	8.13e-07	4.54e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CA—malignant glioma	8.1e-07	4.52e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CA—malignant glioma	7.93e-07	4.43e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—malignant glioma	7.93e-07	4.43e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—malignant glioma	7.9e-07	4.41e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTP1—malignant glioma	7.87e-07	4.4e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—malignant glioma	7.83e-07	4.38e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—malignant glioma	7.76e-07	4.33e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—malignant glioma	7.67e-07	4.29e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CB—malignant glioma	7.67e-07	4.28e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CD—malignant glioma	7.66e-07	4.28e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAT—malignant glioma	7.66e-07	4.28e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MYC—malignant glioma	7.66e-07	4.28e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAV1—malignant glioma	7.64e-07	4.27e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—malignant glioma	7.59e-07	4.24e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—malignant glioma	7.58e-07	4.24e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CA—malignant glioma	7.53e-07	4.21e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGFR—malignant glioma	7.49e-07	4.18e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—malignant glioma	7.36e-07	4.11e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—malignant glioma	7.34e-07	4.1e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.3e-07	4.08e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—malignant glioma	7.25e-07	4.05e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NCOR1—malignant glioma	7.23e-07	4.04e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.22e-07	4.03e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KRAS—malignant glioma	7.07e-07	3.95e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CG—malignant glioma	6.96e-07	3.89e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—malignant glioma	6.71e-07	3.75e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CB—malignant glioma	6.68e-07	3.73e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—malignant glioma	6.64e-07	3.71e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTEN—malignant glioma	6.62e-07	3.7e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—malignant glioma	6.62e-07	3.7e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—malignant glioma	6.62e-07	3.7e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CA—malignant glioma	6.5e-07	3.63e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—malignant glioma	6.48e-07	3.62e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.29e-07	3.52e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—malignant glioma	6.29e-07	3.51e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—malignant glioma	6.24e-07	3.48e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—malignant glioma	6.15e-07	3.44e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CD—malignant glioma	6.12e-07	3.42e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAV1—malignant glioma	5.89e-07	3.29e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTEN—malignant glioma	5.77e-07	3.22e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTEN—malignant glioma	5.44e-07	3.04e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.37e-07	3e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CB—malignant glioma	5.33e-07	2.98e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—malignant glioma	5.31e-07	2.97e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—malignant glioma	5.28e-07	2.95e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—malignant glioma	5.18e-07	2.9e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.72e-07	2.64e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.67e-07	2.61e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTEN—malignant glioma	4.61e-07	2.57e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.11e-07	2.3e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—malignant glioma	4.08e-07	2.28e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CA—malignant glioma	4.07e-07	2.27e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.84e-07	2.14e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—malignant glioma	3.82e-07	2.13e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTEN—malignant glioma	3.56e-07	1.99e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—malignant glioma	3.33e-07	1.86e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.25e-07	1.82e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—malignant glioma	3.13e-07	1.75e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—malignant glioma	2.65e-07	1.48e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.51e-07	1.4e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—malignant glioma	2.05e-07	1.14e-06	CbGpPWpGaD
